The FDA on Tuesday released a warning letter sent to China-based drugmaker Jiangsu Hengrui Pharmaceuticals, finding the company failed at multiple levels to ensure its …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Brolucizumab (Beovu) proved noninferior to aflibercept (Eylea) for visual outcomes among patients with diabetic macular edema (DME), the phase III KINGFISHER trial showed. In over
Along with all global sectors, the dairy industry is working to reduce its environmental impact as we look toward a shared 2050 net zero future.
HAMBURG, Germany — A hybrid closed-loop insulin therapy system significantly improved glycemic control among pregnant women with type 1 diabetes, the randomized AiDAPT trial showed.